Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 973 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Birmingham, Alabama (0.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
University of Alabama at Birmingham - Children's of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Syndax Pharmaceuticals
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Centers of Alabama — Homewood, Alabama (3.9 mi)
· Sponsor: Pacific Edge Limited
Providing an Optimized and Empowered Pregnancy for You (POPPY) Aim 3: Randomized Controlled Trial
Pregnancy Complications, Maternal Distress
N/A
Interventional 400 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
004 — Birmingham, Alabama (0.6 mi)
· Sponsor: Corcept Therapeutics
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Type I Diabetes
Phase 2
Interventional 72 participants sought
University of Alabama at Birmingham - Department of Medicina — Birmingham, Alabama (0.6 mi)
· Sponsor: Op-T LLC
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
HIV Prevention, HIV Risk
N/A
Interventional 125 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Extreme Prematurity, Enteral Nutrition
Phase 1, Phase 2
Interventional 150 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: New York Medical College
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
O Neal Comprehensive Cancer Center at UAB — Birmingham, Alabama (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Urology Centers Of Alabama Pc — Homewood, Alabama (3.9 mi)
· Sponsor: Novartis Pharmaceuticals
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Alabama Oncology — Birmingham, Alabama (0.6 mi)
· Sponsor: Revolution Medicines, Inc.
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Birmingham, AL — Birmingham, Alabama (0.6 mi)
· Sponsor: Mediar Therapeutics
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of California, San Francisco
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
Knee Osteoarthritis
Phase 3
Interventional 300 participants sought
Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama (0.6 mi)
· Sponsor: Doron Therapeutics Inc.
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Major Depression
Phase 3
Interventional 240 participants sought
Birmingham VA Medical Center, Birmingham, AL — Birmingham, Alabama (0.6 mi)
· Sponsor: VA Office of Research and Development
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Annovis Bio Inc.
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Edwards Lifesciences
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
N/A
Interventional 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham